Joshua T. Brumm, CEO: Crescent Biopharma CBIO Planned sale · Filed 09/16

Trade details

Type: Planned sale notice
Stock: Crescent Biopharma CBIO
Person: Joshua T. BrummCEO
Planned sale date: 26/09/16
Filed: 26/09/16

More to sell after $761.3K in 3 months

Crescent Biopharma trades, last 26 weeks

What else happened in Crescent Biopharma around then

Filed or reported within 30 days of the trade day · 08/17~10/16

Joshua T. Brumm's recent trades

Joshua T. BrummCEO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$154.8K
9,013 sh
$154.8K
Filed 09/17
Traded 09/18
Joshua T. BrummCEO
Sell10b5-1 planCrescent Biopharma
Sell10b5-1 plan
Crescent Biopharma
CBIO
$761.1K
42,305 sh
$761.1K
Filed 06/23
Traded 06/22
Joshua T. BrummCEO & President
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$5.1M
202,238 sh
$5.1M
Filed 24/03/12
Traded 24/03/08
Joshua T. BrummCEO & President
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$4.3M
160,670 sh
$4.3M
Filed 24/03/12
Traded 24/03/08
Joshua T. BrummCEO & President
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1M
40,072 sh
$1M
Filed 24/03/12
Traded 24/03/11

Joshua T. Brumm, CEO — plans to sell 1,771 sh of Crescent Biopharma CBIO · $33.3K · around 09/16 · 10b5-1 plan | Whalegun